Phase 1 Borderline Personality Disorder Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

A Study to Test How BI 3031185 is Tolerated by People With Borderline Personality Disorder or Attention-deficit/Hyperactivity Disorder

Attention Deficit Hyperactivity DisorderBorderline Personality Disorder

Boehringer Ingelheim96 enrolled12 locationsNCT07001475

Recruiting

Phase 1Phase 2

Brain Signal Training to Enhance Affect Down-regulation

Borderline Personality Disorder

Central Institute of Mental Health, Mannheim164 enrolled6 locationsNCT06626789